A summary of current health news including Cigna's profit decline, Robert F. Kennedy Jr.'s Senate hearings, an Ebola outbreak ...

Co., Inc. (NYSE:MRK), a global healthcare leader, faces a complex landscape of opportunities and challenges as it navigates the competitive biopharmaceutical industry. This comprehensive analysis ...

Forward-Looking Statement of Merck & Co., Inc., Rahway ... health care legislation in the United States and internationally; global trends toward health care cost containment; technological ...

Herrmann will continue in her role as chief of staff to EVP and chief communications and public affairs officer Cristal Downing.

A global pharmaceutical company partnered with DelveInsight to create a robust and simplified solution enabling its top ...

Merck gained Winrevair in its $11.5 billion acquisition of Acceleron in 2021 and got it across the FDA finish line in March of 2024 based on results from the phase 3 STELLAR trial.

In this article, we are going to take a look at where Merck & Co., Inc. (NYSE ... According to S&P Global, from the past 30 years up until June 2021, the market returned 10.6%, while the index ...

We recently published a list of 12 Best Dow Stocks to Buy Right Now. In this article, we are going to take a look at where ...

Merck & Co., Inc. (NYSE:MRK) is a leading global pharmaceutical company committed to discovering, developing, and delivering innovative medicines and vaccines to improve human and animal health.

The latest health news includes Robert F. Kennedy Jr.'s nomination, Abbott's strategy amid global challenges, and Purdue Pharma's opioid settlement. It highlights company strategies, profits, and ...

As part of our mission to enable global access to personalized medicine ... first players in the EU market for the oncology diagnostic market. Merck, a leading science and technology company, operates ...

Today's Research Daily features a real-time update on the Q4 earnings season and fresh Chevron (CVX), Merck (MRK), QUALCOMM ...